Home » Clinical development » TIARA: Autologous Tregs for Aplastic Anaemia
TIARA: Autologous Tregs for Aplastic Anaemia

Research area:

Rare disease

Disease:

Aplastic anaemia

Intervention:

Therapeutics – ATMP

Phase:

Phase I

Funding awarded to

King’s College London

Public registration details (where available)

NCT05386264

Visit this trial’s project page

Related news

Dementia Consortium funds Manchester based team targeting immune system in search for new dementia treatments

Read more: Dementia Consortium funds Manchester based team targeting immune system in search for new dementia treatments

MRC Technology invests £7 million to expand its diagnostics research capability in Scotland

Read more: MRC Technology invests £7 million to expand its diagnostics research capability in Scotland

UK Drug Discovery Consortium symposium

Read more: UK Drug Discovery Consortium symposium